Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu
about
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimenLarger versus smaller dose of the same drug/s regimen for metastatic breast cancerGranulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent mannerCompliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experienceDose-dense adjuvant chemotherapy for primary breast cancer.American Society for Clinical Oncology 39th Annual Meeting, Chicago, Illinois, USA, 31 May to 3 June 2003: breast cancer neoadjuvant and adjuvant chemotherapy--prognostic and predictive markers8th international conference: primary therapy of early breast cancer, St Gallen, Switzerland, March 12-15 2003Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16-20 March 2004Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk PatientsChemotherapy in Premenopausal Breast Cancer PatientsProgress in adjuvant chemotherapy for breast cancer: an overviewG-CSF and GM-CSF in NeutropeniaAdjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineHematopoietic growth factors: personalization of risks and benefitsIntegrated PK-PD and agent-based modeling in oncologyCurrent treatment of early breast cancer: adjuvant and neoadjuvant therapyAdjuvant treatment for older women with invasive breast cancerPhase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancerFifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)Genome remodelling in a basal-like breast cancer metastasis and xenograftEvolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategiesDose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer PatientsSystemic therapy for bladder cancer finally comes into a new age.German Adjuvant Intergroup Node-positive Study (GAIN): A Phase III Trial Comparing Two Dose-Dense Regimens (iddEPC vs. ddEC-PwX) in High-Risk Early Breast Cancer Patients.AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer.A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: a Gynecologic Oncology Group study.Neoadjuvant epirubicin, gemcitabine and docetaxel for primary breast cancer: long-term survival data and major prognostic factors based on two consecutive neoadjuvant phase I/II trials.Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data.Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy.Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck.Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer.Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival.Weekly paclitaxel plus carboplatin is an effective nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast cancer.Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results
P2860
Anger Control Training for Youth With Tourette SyndromeWill CPAP Reduce Length Of Respiratory Support In Premature Infants?Laparoscopic Assisted Versus Open Resection for Colorectal CarcinomaTargeted Naltrexone for Problem DrinkersAcupuncture in Chronic Migraine: A Randomized Controlled TrialGo Fish: Omega-3 Fatty Acid Supplementation in Diabetes-Related Kidney DiseaseTargeting HIV Risk Behaviors in Juvenile Drug Court-Involved YouthMemantine Versus Donepezil in Early Stages of Alzheimer's DiseaseTreatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1)Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous LinesIn-Person vs e-Health Mindfulness-Based Intervention for Adolescents With Chronic IllnessChicago Urban Resiliency Building (CURB)Dorsal Penile Block for Post-Robotic Prostatectomy Foley DiscomfortPilot Study of a National Screening Programme for Bowel Cancer in NorwayInterpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent MothersPresent- Versus Past-focused Therapy for PTSD and Substance Use DisorderKick Out Parkinson's Disease 2Effectiveness of Percutaneous Needle AponeurotomyComparison of Low, Moderate and High Carbohydrate Diet on Insulin Requirements and Metabolic Control in Type 1 Diabetes
P921
Q21092375-92BED9A7-67C6-4D60-88EF-8C95E87664BCQ24194953-CECF8629-F1B2-4A7C-B770-C7FC76C0E280Q24683680-5E51C47E-32DF-4C78-861F-F3E1C6272EB5Q24792539-CF3749F4-86F9-4AFF-A3B5-49419DB07942Q24797259-6D5BADAC-2721-4378-80C7-8EE5FA37C3DEQ24802793-5556099D-DC52-490B-BEF2-B795BFA264FEQ24803899-FD87414F-EF6C-44CF-AAE4-6BD9E58AB49CQ24806223-715CC3E6-CAB7-440F-8E40-15855E486150Q25257621-D0406211-4C1D-46E3-BE41-552A04AF9D3DQ26751253-BEFD1F25-B160-4677-88E8-C24A4ED8ADF7Q26774622-F79FC92C-7AFB-4D1B-8A61-6E02C3AD6662Q26798078-D1102515-B79A-4DDD-AAD4-D6377827F6A4Q26800954-5AFDB69C-81DB-4E29-8303-D2498CF50C72Q26853619-0C98096C-4016-4055-9CA1-059355B52A62Q26866922-64CC4BFE-FEE9-4D61-BBE1-2D87C477BF30Q27006577-9EBB9A21-35EC-4B89-B122-3751487260B3Q27011658-8B316773-7220-4B71-BD7C-C45627915AC9Q28066744-E741AB61-9C20-4F53-9FED-8F6AF305C345Q28240692-F8A1603F-F54C-42FA-BC49-825F0320B2A5Q28270514-9AF3FBB2-EDE1-4455-8D6A-5B10C21EB699Q28395637-09501C78-A922-43B0-8EB7-79C2C7472EEFQ28471733-452A7DFC-BAC9-4530-A487-1FAF2CF1ECF3Q28550661-DC748D08-BBA1-4904-A3E8-7B39721562D6Q30249047-22448723-8003-4B7E-A521-402BFAA5FC0EQ30313214-44A2F9A6-62C6-4E23-821F-3A999B878732Q30318240-2344DA1B-91FC-41D8-97F7-1B0AFC0A18C2Q30406114-2E2A0ACB-BD4E-4199-8B07-464981778DCFQ30430866-5C9BCB11-0D22-4BB3-8ED1-C3ACB0EEF11BQ30588206-73065D11-F2BD-4537-8EB1-BA1C892D6F4FQ30845285-04780355-D5A1-4A3A-82F8-9413B353DB13Q33224014-67BC6A88-F99E-47BA-8975-3C42A14858B7Q33362114-8C419A82-8056-4DC3-8D9B-1B8B8F6890E4Q33369478-0F7688C9-1508-4FE9-B8E7-4D4422DF8404Q33373879-190EE88F-2CE0-4E86-9AB9-4119D7EE1AECQ33383943-E191A488-893F-4114-8906-B00E1EE2E7A8Q33384057-D8FBD35B-0E9A-4037-B32B-BCE87D0B1DB0Q33388534-95050137-FE8A-436D-997F-7505DE35E8CEQ33395356-4275D17A-239C-40CA-A929-06503B3FB373Q33396185-1E6F7C6F-C095-4229-8638-02D4A705406FQ33397922-0321A0F0-CFA2-4CF3-85B2-AFC84B54AB78
P2860
Q61918414-F31B691D-5650-41B2-ACF2-27B32F34D0F8Q61918429-92DD15BA-FD8D-493F-AB3A-B24D5C6A6634Q61918519-94778731-C926-4EB7-B50A-059E5EEAC304Q61933551-C57E8E9F-116D-4D3F-B2B4-6766EA89420FQ61936558-DEEBE470-8CBD-47BB-92C5-5AF25DED1210Q61936989-6656AA68-3928-4285-961B-B71089660E30Q61956032-F15C450E-838A-4A2C-9E00-B8FFB885762BQ61980011-B1D75F31-F62C-47FF-B4B5-692FB3EDD292Q62026003-08E5F747-D4EE-4B9F-AB22-35E0AE44CC8FQ62105080-E525C7AC-00F1-4571-999A-4844174A23E5Q62819070-A2DF1AEA-892F-4095-A450-D5FB8029C41CQ62822807-21692D17-BE9F-48B9-B101-2BC7BD607D1FQ63229392-1F8C6D80-26FC-4CF1-AEFC-3F65FAD1DB7AQ63316706-BD3ED8E8-05A2-4DAE-BA72-DC0E59E9AFDFQ63318725-27A71E3F-D10D-44FB-9EA5-F906A68FB6C5Q63319770-5837D0C5-A879-4905-9D1F-8AF02C2862FCQ63572770-65680E63-1179-4F8D-93CE-0DC61B0DB8E1Q63576331-CD04D2F3-B0C6-4318-B541-88FB898130D6Q63582435-8B0EC4E5-2F83-481F-B7D6-F736C041DB13Q63592191-A8A9EACE-C736-48AD-B0FC-FD05F4FB4A57Q63595860-EB5BBD07-3629-4BD6-86EC-36B4FCB289BF
P921
Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu
description
article
@en
im April 2003 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2003
@uk
name
Randomized Trial of Dose-Dense ...... oup Trial C9741/Cancer and Leu
@en
Randomized Trial of Dose-Dense ...... oup Trial C9741/Cancer and Leu
@nl
type
label
Randomized Trial of Dose-Dense ...... oup Trial C9741/Cancer and Leu
@en
Randomized Trial of Dose-Dense ...... oup Trial C9741/Cancer and Leu
@nl
prefLabel
Randomized Trial of Dose-Dense ...... oup Trial C9741/Cancer and Leu
@en
Randomized Trial of Dose-Dense ...... oup Trial C9741/Cancer and Leu
@nl
P2093
P356
P1476
Randomized Trial of Dose-Dense ...... oup Trial C9741/Cancer and Leu
@en
P2093
Barbara L. Smith
Carolyn I. Sartor
Clifford Hudis
Constance Cirrincione
David Hurd
Donald A. Berry
Edith A. Perez
Eleanor H. Leung
Eric P. Winer
Hyman B. Muss
P304
P356
10.1200/JCO.2003.09.081
P407
P50
P577
2003-04-15T00:00:00Z